文献速递肿瘤 PET/CT

部分容积校正在肿瘤PET研究中的影响:系统综述与Meta分析

Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-08-04

该系统综述纳入31项研究,评估部分容积校正(PVC)在肿瘤PET诊断、分期、预后和疗效评估中的影响。6项肺结节诊断研究(679个病灶)的Meta分析显示PVC后诊断准确性无显著变化(p=0.222);PVC对非小细胞肺癌和食管癌预后评估无改善,对头颈癌有改善。结论认为现有证据不支持在标准临床PET实践中常规应用PVC。

要点

  • 31项研究总体质量良好,PVC在诊断和淋巴结分期中呈现灵敏度升高、特异度降低的强趋势。
  • 6项肺结节诊断研究(679个病灶)Meta分析显示PVC后诊断准确性无显著变化(p=0.222)。
  • PVC对非小细胞肺癌和食管癌预后评估无改善,对头颈癌有改善;对乳腺癌和直肠癌疗效评估无改善,在转移性结直肠癌中变差。

核心结论

  • 迄今积累的证据不支持在标准临床PET实践中常规应用部分容积校正(PVC)。
  • 肿瘤PET中首选的PVC方法学尚需达成共识。
  • 部分容积校正数据应作为未校正数据的辅助,而非替代。

研究设计与样本

  • 系统综述与Meta分析,按照PRISMA声明检索PubMed和Embase数据库,纳入从建库至2016年5月9日的研究。
  • 两名评价者独立筛选摘要和符合条件的全文,并依据QUADAS-2和QUIPS标准进行质量评价。
  • 对一组相似的诊断研究,采用双变量Meta回归进行统计合并。
  • 共31项研究符合纳入标准,总体研究质量良好。

主要发现

  • 在诊断和淋巴结分期方面,PVC呈现灵敏度升高、特异度降低的强趋势。
  • 6项肺结节诊断研究(679个病灶)的Meta分析显示,PVC后诊断准确性无显著变化(p=0.222)。
  • PVC对非小细胞肺癌和食管癌的预后评估无改善,对头颈癌的预后评估有改善。
  • PVC对(局部晚期)乳腺癌或直肠癌的疗效评估无改善,在转移性结直肠癌中疗效评估变差。

关键数值与推荐

  • 6项肺结节诊断研究(679个病灶)Meta分析:PVC后诊断准确性无显著变化(p=0.222)。

临床怎么用

  • 原文结论认为现有证据不支持在标准临床PET实践中常规应用PVC。
  • 原文结论认为部分容积校正数据应作为未校正数据的辅助,而非替代。
  • 原文结论认为肿瘤PET中首选的PVC方法学尚需达成共识。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Positron-emission tomography can be useful in oncology for diagnosis, (re)staging, determining prognosis, and response assessment. However, partial-volume effects hamper accurate quantification of lesions <2-3× the PET system's spatial resolution, and the clinical impact of this is not evident. This systematic review provides an up-to-date overview of studies investigating the impact of partial-volume correction (PVC) in oncological PET studies. METHODS: We searched in PubMed and Embase databases according to the PRISMA statement, including studies from inception till May 9, 2016. Two reviewers independently screened all abstracts and eligible full-text articles and performed quality assessment according to QUADAS-2 and QUIPS criteria. For a set of similar diagnostic studies, we statistically pooled the results using bivariate meta-regression. RESULTS: Thirty-one studies were eligible for inclusion. Overall, study quality was good. For diagnosis and nodal staging, PVC yielded a strong trend of increased sensitivity at expense of specificity. Meta-analysis of six studies investigating diagnosis of pulmonary nodules (679 lesions) showed no significant change in diagnostic accuracy after PVC (p = 0.222). Prognostication was not improved for non-small cell lung cancer and esophageal cancer, whereas it did improve for head and neck cancer. Response assessment was not improved by PVC for (locally advanced) breast cancer or rectal cancer, and it worsened in metastatic colorectal cancer. CONCLUSIONS: The accumulated evidence to date does not support routine application of PVC in standard clinical PET practice. Consensus on the preferred PVC methodology in oncological PET should be reached. Partial-volume-corrected data should be used as adjuncts to, but not yet replacement for, uncorrected data.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Cysouw MCF, Kramer GM, Schoonmade LJ, et al. Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2017. PMID: 28776088. doi:10.1007/s00259-017-3775-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。